Chemicals and Drugs

HCV NS3-4A Protease Inhibitors

A direct acting antiviral compound that inhibits hcv ns3-4a protease. It is used to treat chronic HEPATITIS C.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A direct acting antiviral compound that inhibits hcv ns3-4a protease. It is used to treat chronic HEPATITIS C.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

MeSH Record

Synonyms

1 entry terms
  • NS3 4A Protease Inhibitors

MeSH Record

Aspects Covered

22 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.

MeSH Record

History Note

2022

MeSH Record

Previous Indexing

  • Hepatitis C (1995-2021)

MeSH Hierarchy

Tree Numbers

  1. D27.505.519w.389w.745w.900.375
  2. D27.505.954.122.388w.769.375

AMA Style

References

  1. National Library of Medicine. HCV NS3-4A Protease Inhibitors. Medical Subject Headings (MeSH). 2026. Unique ID D000088802. http://id.nlm.nih.gov/mesh/2026/D000088802
  2. HCV NS3-4A Protease Inhibitors. In: Wikidata. https://www.wikidata.org/wiki/Q25378718